Lotus Pharmaceuticals, Inc. (LTUS) Financial Statements
$0.00OTC: LTUSMarket Cap $108376
Lotus Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.